Parmax Pharma Ltd - 540359 - Shareholding for the Period Ended September 30, 2021
Parmax Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here14-10-2021
14-10-2021
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Alkesh M Gopani12-10-2021
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravina Mahasukhlal Gopani07-10-2021
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Alkesh M Gopani07-10-2021
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Alkesh M Gopani05-10-2021
Parmax Pharma Ltd - 540359 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- YASH VORADesignation :- Company Secretary and Compliance Officer05-10-2021
Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Revised voting results of 27th Annual General Meeting of the Company.29-09-2021
Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Demise
Intimation of sad demise of Mrs. Asha Daftary, Independent Director of the Company.27-09-2021
Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201523-09-2021